4893 items matching your search terms.

Interventions for prevention of postoperative atrial fibrillation and its complications after cardiac surgery: a meta-analysis

Burgess, D Kilborn, M Keech, A

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial

Burmeister, B.H. Smithers, B.M. Gebski, V. Fitzgerald, L. Simes, R.J. Devitt, P. Ackland, S. Gotley, D.C. Joseph, D. Millar, J. North, J. Walpole, E.T. Denham, J.W. for the Trans-Tasman Radiation Oncology Group (TROG) and the Australasian Gastro-Intestinal Trials Group (AGITG),
LANCET ONCOLOGY, 2005     DOI:10.1016/s1470-2045(05)70288-6

Single index of multimorbidity did not predict multiple outcomes

Byles, JE D'Este, C Parkinson, L O'Connell, R Treloar, C

On the relation between initial value and slope

Byth, K Cox, DR

Single agent versus combination chemotherapy for metastatic breast cancer

Carrick, S; Parker, S; Wilcken, N; Ghersi, D; Marzo, M; Simes, J

Imatinib mesylate in advanced gastrointestinal stromal tumors: survival analysis of the intergroup EORTC/ISG/AGITG randomized trial in 946 patients

Casali, PG Verweij, J Kotasek, D LeCesne, A Reichardt, P Blay, JY Issels, R Rychter, MD Van Glabbeke, M Judson, I

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Cholesterol Treatment Trialists Collaborators, Baigent, C Keech, A Kearney, PM Blackwell, L Buck, G Pollicino, C Kirby, A Sourjina, T Peto, R Collins, R Simes, R

Obesity is a risk factor for major coronary heart disease events in patients with CHD: results from the LIPID study. The LIPID study investigators

Colquhoun, DM; Kirby, A; Keech, AC; Simes, RJ; Hague, WE; Hamilton-Craig, I; Tonkin, AM

Evaluating methods to improve recruitment and consent to randomised controlled trials in neonatology: two cluster studies in the INIS network

Cust, AE Sitha, S Hague, W Duggal-Beri, P Barsenbach, R Tarnow-Mordi, WO

Patients' preferences for adjuvant endocrine therapy in early breast cancer: What makes it worthwhile?

Duric, VM Fallowfield, LJ Saunders, C Houghton, J Coates, AS Stockler, MR

Patients' preferences for adjuvant chemotherapy in early breast cancer: What makes AC and CMF worthwhile now?

Duric, VM; Stockler, MR; Heritier, S; Boyle, F; Beith, J; Sullivan, A; Wilcken, N; Coates, AS; Simes, RJ

Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancer

Duric, V; Stockler, MR; Butow, P; Sharpe, L; Heritier, S; Beith, J; Boyle, F; Wilcken, N; Coates, A; Simes, RJ

The effect of fenofibrate on major coronary disease events in people with type 2 diabetes: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

FIELD Study Investigators,

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

FIELD Study Investigators, Keech, A Simes, RJ Barter, P Best, J Scott, R Taskinen, MR Forder, P Pillai, A Davis, T Glasziou, P Drury, P Kesaniemi, YA Sullivan, D Hunt, D Colman, P d'Emden, M Whiting, M Ehnholm, C Laakso, M

Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]

FIELD Study Investigators, Scott, R Best, J Forder, P Taskinen, M.R. Simes, J Barter, P Keech, A
CARDIOVASCULAR DIABETOLOGY, 2005     DOI:doi:10.1186/1475-2840-4-13